Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781

Methodological index for non‐randomized studies ( MINORS ): development and validation of a new instrument

Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003) · ANZ Journal of Surgery · doi:10.1046/j.1445-2197.2003.02748.x · Cited by 7,603

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease

Desalegn, H., Farias, R., Hudson, D., Idalsoaga, F. J., Cabrera, D., Díaz, L. A., & Arab, J. P. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.30 · Cited by 8

Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

Lucaciu, R. L., Coste, S. C., Hangan, A. C., Iancu, M., Orasan, O. H., Cozma, A., Bogdan, S. G., & Procopciuc, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125717 · Cited by 11

Management of patients with type 2 diabetes and MASLD: An overview and joint statement

Chouik, Y., Canivet, C. M., Julla, J., Mouillot, T., Parlati, L., Rouland, A., Smati, S., Tramunt, B., Anty, R., Boursier, J., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101709 · Cited by 9

Immunometabolic integration in therapeutic strategies for managing MASLD

González-Serrano, S., Onoiu, A.-I., Camps, J., & Joven, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1693753 · Cited by 8

Should bariatric surgery be offered for hepatocellular adenomas in obese patients?

Goonawardena, J., Ratnayake, C., Cheung, K. T., & Fox, A. M. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.06.043 · Cited by 8

Optimal Management of Obesity in Transplant Candidates and Recipients

Lam, J., Khan, M. Q., Watt, K. D. S., & Diwan, T. S. (2024) · Current Transplantation Reports · doi:10.1007/s40472-024-00434-8 · Cited by 8

The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease

Fouad, Y., Elwakil, R., Sanai, F. M., Ojo, O. S., Awadhi, S. A., Ocama, P., Abdelkader, N. A., Al‐Busafi, S. A., Awuku, Y. A., Zaki, S., et al. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102180 · Cited by 7

Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis

Kumar, J., Mohsin, S., Hasan, M., Bilal, A. R., Ali, K. M., Umer, A. M., Hadi, D. Z. M., Nandlal, S., & Kumar, S. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102261 · Cited by 7

Preoperative risk evaluation and optimization for patients with liver disease

Bhalla, S., McQuillen, B., Cay, E., & Reau, N. S. (2023) · Gastroenterology report · doi:10.1093/gastro/goae071 · Cited by 7

Bariatric Surgery Affects Plasma Levels of Alanine Aminotransferase Independent of Weight Loss: A Registry-Based Study

Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Carmi, S., Schyr, R. B., Romano‐Zelekha, O., & Ben‐Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122724 · Cited by 9

HCC in metabolic syndrome: current concepts and future directions

Zampaglione, L., Ferrari, J., Pedica, F., & Goossens, N. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.22 · Cited by 7

The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods

Meneses, D., Olveira, A., Corripio, R., Méndez, M., Romero, M., Viñuela, I. C., de Villar, N. G. P., & de-Cos-Blanco, A. I. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06153-2 · Cited by 7

Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective

Kim, K. H., Kim, Y., Seo, K. I., & Seo, K. W. (2022) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2022.102.6.353 · Cited by 7

Comparative effects between old and new antidiabetic agents on metabolic- associated fatty liver disease (MAFLD)

Scheen, A. J. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100145 · Cited by 7

Approach to Elevated Liver Enzymes

Rosenberg, J. J., Sola, O. I., & Visconti, A. (2023) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2023.03.007 · Cited by 7

Liver health and the interplay between obesity, alcohol and bariatric surgery

Geerts, A. M., Onghena, L., & Lefere, S. (2023) · Acta gastro-enterologica belgica · doi:10.51821/86.2.11553 · Cited by 7

Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients

Leite, C., Starosta, R. T., Trindade, E. N., Monteiro, E. D. M., Pereira, P. F., Trindade, M. R. M., Álvares‐da‐Silva, M. R., & Cerski, C. T. S. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04722-x · Cited by 7

Fighting liver fat

Koeckerling, D., Tomlinson, J., & Cobbold, J. (2020) · Endocrine Connections · doi:10.1530/ec-20-0174 · Cited by 7

Statins for treatment of chronic liver disease

Marrache, M. K., & Rockey, D. C. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000716 · Cited by 8

Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses

Zou, Z., Zeng, J., Ren, T., Shi, Y., Yang, R., & Fan, J. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00183 · Cited by 7

Vertical Sleeve Gastrectomy Versus Comprehensive Lifestyle Intervention for Adolescents With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Controlled Cohort Study

Yodoshi, T., Ollberding, N. J., McNeill, M., Ley, S. L., Kirk, S., Kleiner, D. E., Arce‐Clachar, A. C., Bramlage, K., Inge, T. H., Helmrath, M. A., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70766 · Cited by 7

The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease

Chuang, T.-J., Ko, C.-W., & Shiu, S. (2023) · Medicine · doi:10.1097/md.0000000000035147 · Cited by 6

Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity

Hupa‐Breier, K. L., Schenk, H. J., Campos-Murguía, A., Wellhöner, F., Heidrich, B., Dywicki, J., Hartleben, B., Böker, C., Mall, J. W., Terkamp, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102104 · Cited by 6

Metabolic Surgery: Paradigm Shift in Metabolic Syndrome/Diabetes Therapy

Rühle, A., Billeter, A. T., & Müller-Stich, B. P. (2022) · Visceral Medicine · doi:10.1159/000521707 · Cited by 6

Advances in fibrosis biomarkers in nonalcoholic fatty liver disease

Ciardullo, S., & Perseghin, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.003 · Cited by 6

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes

Chen, C., Zhang, Y., Fan, Y., Ying, Z., Su, Q., Li, X., & Qin, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1108442 · Cited by 6

Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery

Schmitz, S. M., Storms, S., Koch, A. H., Stier, C. K., Kroh, A., Rheinwalt, K. P., Schipper, S., Hamesch, K., Ulmer, T. F., Neumann, U. P., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061595 · Cited by 6

Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting

Collins, H., Beban, G. R., Windsor, J. A., Ram, R., Orr, D. W., Evennett, N. J., & Loveday, B. P. T. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04161-3 · Cited by 6

Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery—a Post Hoc Analysis of the FibroTest Prospective Study

Codjia, T., Rebibo, L., François, A., Brasse‐Lagnel, C., Huet, E., Bekri, S., Pattou, F. N., Regimbeau, J., & Schwarz, L. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05402-0 · Cited by 6

How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?

Libman, H., Jiang, Z. G., Tapper, E. B., & Reynolds, E. E. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1125 · Cited by 6

A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease

Chu, X., Karasinski, K., Donellan, S., Kaniper, S., Wood, G. C., Shi, W., Edwards, M. A., Soans, R. S., Still, C. D., & Gerhard, G. S. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01848-0 · Cited by 6

Targeting visceral and ectopic adiposity: Pharmacological and surgical interventions beyond global weight loss

Güldan, M., Özbek, L., Abdel‐Rahman, S. M., Narin, A. E., Orak, H. İ., Goren, H. K., Afşar, B., Rossing, P. R., & Kanbay, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70019 · Cited by 7

Endoscopic bariatrics: Current status and emerging technologies

Moutzoukis, M., Argyriou, K., Manolakis, A. C., Kapsoritakis, A. N., & Christodoulou, D. K. (2025) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v17.i10.109031 · Cited by 5

Diabetes and the liver

Dadey, E., Lim, T., & Makaronidis, J. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100528 · Cited by 5

Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease

Kirkpatrick, K. P., Paull-Forney, B. G., Okut, H., & Schwasinger-Schmidt, T. E. (2021) · Kansas Journal of Medicine · doi:10.17161/kjm.vol14.14984 · Cited by 5

Biomarkers reflecting pericellular fibrosis improve together with liver histology after bariatric surgery in early non-alcoholic fatty liver disease

Lønsmann, I., Pedersen, J. S., Krag, A. A., Hansen, T. F., Karsdal, M. A., Leeming, D. J., Nielsen, M. J., & Bendtsen, F. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2022.12.012 · Cited by 5

Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet

Srivastava, A., Stevenson, M., Lee, J., Hall, C. E., Palaia, T. A., Zhao, C. L., Lau, R. G., BRATHWAITE, C. E. M., & Ragolia, L. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06053-5 · Cited by 4

The role of bariatric surgery in liver transplantation: timing and type

Safavi, D., Creavin, B., Gallagher, T. K., & Kelly, M. E. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02606-5 · Cited by 4

Can Nonalcoholic Steatohepatitis Be Surgically Cured?

Aminian, A., Wilson, R. L., Al‐Kurd, A., Bena, J., Fayazzadeh, H., Alkhouri, N., Nissen, S. E., & Dasarathy, S. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005914 · Cited by 4

The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice

Stevenson, M., Srivastava, A., Nácher, M., Hall, C. E., Palaia, T. A., Lee, J., Zhao, C. L., Lau, R. G., Ali, M. A., Park, C. Y., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-023-07052-w · Cited by 4

Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery

Brol, M. J., Drebber, U., Yu, X., Schierwagen, R., Gu, W., Plamper, A., Klein, S., Odenthal, M., Uschner, F. E., Praktiknjo, M., et al. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.02.006 · Cited by 4

Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort study

Yang, C., Chen, J., Chen, C.-Y., Kao, C.-Y., Huang, S.-F. K., Chang, W.-Y., Tu, H., Huang, J., Yu, M., & Tai, C. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.11.007 · Cited by 4

Indikationsqualität in der Adipositaschirurgie

Billeter, A. T., Schwarz, A., Rühle, A., Boskovic, A., Nickel, F., Zech, U., Wagenlechner, P., & Müller-Stich, B. P. (2020) · Der Chirurg · doi:10.1007/s00104-020-01183-x · Cited by 4

Impact of Bariatric Surgery on Unplanned Hospital Admissions for Infection

Cundy, T., Gamble, G. D., Yi, E., Evennett, N. J., & Beban, G. R. (2022) · Obesity Surgery · doi:10.1007/s11695-022-05975-4 · Cited by 4

Treatment and Management of Gastrointestinal Disorders

Montgomery, G., Patel, A., & Pfeil, S. A. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.010 · Cited by 4

Pharmacological, Endoscopic, Metabolic, and Surgical Procedures for Nonalcoholic Fatty Liver Disease

Xanthakos, S. A. (2021) · Clinical Liver Disease · doi:10.1002/cld.1030 · Cited by 4

Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass?

Pereira, P. F., von Diemen, V., Trindade, E. N., Michalczuk, M. T., Cerski, C. T. S., Mussi, A. C., Aldabe, D. F., Branchi, R. N., Knijnik, P. G., Brum, P. W., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04513-4 · Cited by 4

Two Trials of Therapeutics for MASH with Liver Fibrosis

Mei, Z., Pu, J., & Shao, Z. (2024) · New England Journal of Medicine · doi:10.1056/nejmc2411003 · Cited by 4

7. Management of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes

Colagiuri, S., & Ceriello, A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112151 · Cited by 3

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

Stupalkowska, W., Henney, A. E., Sheu, E. G., Alam, U., & Cuthbertson, D. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70173 · Cited by 6

Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data

Crommen, S., Rheinwalt, K. P., Plamper, A., Rösler, D., Weinhold, L., Metzner, C., & Egert, S. (2024) · Nutrients · doi:10.3390/nu16183210 · Cited by 4

The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity

Shi, X., Liu, Y., Chen, Y., Jiang, Z., Ye, M. S., & Wang, J. (2025) · Pediatric Obesity · doi:10.1111/ijpo.70017 · Cited by 3

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

Andreev, K. A., Skirdenko, Y. P., Николаев, Н. А., Livzan, M. A., Горбенко, А. В., Fedorin, M. M., & Сергеевна, К. Т. (2022) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2021-4-112-122 · Cited by 4

Relationship between dietary intake components and hepatic fibrosis in those with obesity before and 1 year after bariatric surgery

Schwenger, K. J. P., Ghorbani, Y., Rezaei, K., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2023) · Nutrition · doi:10.1016/j.nut.2023.112095 · Cited by 3

Natural History of Nonalcoholic Fatty Liver Disease

Ismaiel, A., Portincasa, P., & Dumitrascu, D. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_3 · Cited by 3

Welches (ist das richtige) Target bei nichtalkoholischer Fettleber (NAFLD)

Huber, Y., Galle, P. R., & Schattenberg, J. M. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1068-3981 · Cited by 3

Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD – a prospective interventional study

Vašura, A., Machytka, E., Urban, O., Macháčková, J., Pavliska, L., Berka, Z., Švagera, Z., & Bužga, M. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101765 · Cited by 2

Decreased liver volume after bariatric surgery and its positive impact on liver function tests and lipid profile

Sarmiento-Cobos, M. F., Adelman, A. E., Murchison, K., Rivera, C. E., Valera, R. J., Montorfano, L. M., Okida, L. F., Wasser, E. J., Menzo, E. L., Szomstein, S., et al. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.12.015 · Cited by 2

Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis

Moosa, A., Variava, E., Calver, A. D., Chita, G., Sabet, N., Ngwenya, S., Papathanasopoulos, M. A., & Omar, T. (2024) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v25i1.1638 · Cited by 3

Management of obesity in advanced chronic liver disease

Caussy, C., & Francque, S. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101749 · Cited by 2

The impact of bariatric and metabolic surgery on the levels of circulating growth differentiation factor 15 in humans

Yassuda, V., Sequeira, B., & Sousa‐Coelho, A. L. D. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01160-8 · Cited by 2

Mitochondrial remodeling in obesity: mechanistic links to impaired energy metabolism and therapeutic perspectives

Neto, W. H. J., Ramos, C. D. O., & de Souza, C. T. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115427 · Cited by 2

Obesity: current state of the problem, multidisciplinary approach. (based on the consensus of the World Gastroenterological Organization “Obesity 2023” and the European guideline on obesity care in patients with gastrointestinal and liver diseases, 2022)

Livzan, M. A., Lyalyukova, E. A., Друк, И. В., Safronova, S. S., Аскерович, Х. А., Martirosian, K. A., Petrosian, V. Y., & Galakhov, Y. S. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-218-10-5-47 · Cited by 3

Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up

Kahani, M., Delasaeimarvi, S., Zandbaf, T., Tabasiyan, M. R., Meshkat, M., Mirsadeghi, S. A. S., & Ghamari, M. J. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07376-1 · Cited by 2

The Glutamate-Serine-Glycine Index as a Biomarker to Monitor the Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease

Tan, N. Y. T., Shumbayawonda, E., Cheng, L. T., Low, A. S. C., Lim, C. H., Eng, A. K. H., Chan, W. H., Lee, P. C., Tay, M. F., Chang, J. P.-E., et al. (2024) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.039.02.20 · Cited by 4

Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations

Hadefi, A., Leprovots, M., Dinsart, G., Marefati, M., Vermeersch, M., Monteyne, D., Pérez-Morga, D. L., Lefort, A., Libert, F., Verset, L., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.100599 · Cited by 2

Metabolic Dysfunction-Associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction: A Bidirectional Relationship with Clinical and Therapeutic Implications

Leite, A. R., Dias, J., Godinho, T., Correia-Chaves, J., Borges‐Canha, M., Lourenço, I. M., Leite-Moreira, A. F., & Neves, J. S. (2024) · Endocrinology Insights · doi:10.1159/000541442 · Cited by 3

Bariatric Surgery Decreases the Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis

Brown, A. M., & Pryor, A. D. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003937 · Cited by 2

Preoperative Level of Leptin Can Be a Predictor of Glycemic Control for Patients with Diabetes Undergoing Bariatric Surgery

Cabrera, L. O., Trindade, E. N., Leite, C., Abegg, E. H., & Trindade, M. R. M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05011-3 · Cited by 2

Clinical and Esophagogastroduodenoscopy Findings in Pediatric Patients With Severe Obesity Evaluated Before Bariatric Surgery

Sivan, R. F., Lev, M. R. B., Silbermintz, A., Mozer‐Glassberg, Y., Seguier‐Lipszyc, E., Shalitin, S., Stafler, P., Tiroler, S., Shamir, R., & Waisbourd‐Zinman, O. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003109 · Cited by 2

Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?

Mandour, M. O., El-Hassan, M., Elkomi, R., & Oben, J. A. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i9.1704 · Cited by 2

CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?

Newton, E., Pan, J., & Chung, W. (2022) · Clinical Liver Disease · doi:10.1002/cld.1226 · Cited by 2

Exercise in the management of metabolic dysfunction-associated fatty liver disease—is more the answer, or is it just one piece of the puzzle?

Nash, E., & Liu, K. (2024) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-686 · Cited by 2

Utility of the Non-Alcoholic Fatty Liver Disease Fibrosis Score in the Evaluation of Individuals with Medically-Complicated Obesity: A Retrospective Study

Nath, A., Shope, T. R., Pardo, I., & Koch, T. R. (2024) · The International Journal of Gastroenterology and Hepatology Diseases · doi:10.2174/0126662906296409240826050717 · Cited by 1

Higher pre-operative non-invasive fibrosis scores are not associated with surgical outcomes in patients with MASLD undergoing metabolic and bariatric surgery

Huynh, L., Kouzmina, E., Zevin, B., & Flemming, J. A. (2025) · Canadian Liver Journal · doi:10.3138/canlivj-2024-0015 · Cited by 1

Progression of liver fibrosis after metabolic bariatric surgery in a MASLD rat model

Mairinger, M., Richwien, P., Eichelter, J., Mölzer, C., Jedamzik, J., Felsenreich, D. M., Sarocchi, F., Büchi, I., Wöran, K., Staufer, K., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.07.019 · Cited by 1

Adjustable Intragastric Balloon for Metabolic Dysfunction–associated Steatotic Liver Disease—Enhanced Weight Loss and Histological Improvement

Kalapala, R., Jagtap, N., Rughwani, H., Asif, S., Sekaran, A., Sharma, M., Kulkarni, A., Rao, P. N., Tyagi, A., & Reddy, D. N. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103152 · Cited by 1

Implementation of a standardized postoperative protocol enhances adherence to postoperative care and quality of life following bariatric surgery

Blume, C. A., Viana, L. V., Maraschin, C. K., Friedman, R., do Nascimento, C., Trindade, M. R. M., Bahia, L., Teló, G. H., & Schaan, B. D. (2025) · Nutrition · doi:10.1016/j.nut.2025.112981 · Cited by 2

Effect of Weight Loss on Clinical Outcomes in Patients With Chronic Gastrointestinal and Liver Diseases

Pugliese, N., Spertino, M., Mercurio, M., Ciardullo, S., Perseghin, G., Hassan, C., Vettor, R., Petta, S., & Aghemo, A. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.10.018 · Cited by 2

MASLD – Krankheitslast, Herausforderungen und neue Therapeutika

Roeb, E. (2025) · Die Gastroenterologie · doi:10.1007/s11377-025-00868-1 · Cited by 1

Analysis of Roux-en-Y Gastric Bypass and High-Fat Feeding Reveals Hepatic Transcriptome Reprogramming: Ironing out the Details

Stevenson, M., Tirumalasetty, M. B., Srivastava, A., Miao, Q., BRATHWAITE, C. E. M., & Ragolia, L. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020479 · Cited by 1

Cholesterol-rich diet exacerbates steatohepatitis in the STAM mouse model

Jonas, W., Gottmann, P., Jähnert, M., Baer, N. B., Schürmann, A., & Vogel, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-45979-z · Cited by 1

Bariatric surgery as a therapeutic strategy for metabolic dysfunction-associated steatotic liver disease in patients with obesity: a narrative review

Cho, Y. (2026) · Journal of Korean Medical Association · doi:10.5124/jkma.26.0056 · Cited by 1

Nutrition in liver disease

Plauth, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00004-5 · Cited by 1

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Bagriy, A. E., Zubov, A. D., Khomenko, M. V., Михайличенко, Е. С., Пылаева, Е. А., Khaustova, N. A., & Bryukhovetskaya, E. V. (2021) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2021-31-2-14-26 · Cited by 1

The Role of Bariatric Surgery in Fatty Liver

Geerts, A. M., & Lefere, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96975 · Cited by 1

Impact of Bariatric Surgery on Non-Alcoholic Fatty Liver Disease - Role of Non-Invasive Tests

Yelkur, K. K., Valeti, M., Kankanala, S., Jekkyreddy, S., & Gade, M. (2022) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_8_21 · Cited by 1

Bariatric metabolic surgery eliminates body mass index as a risk factor for unemployment

Halvachizadeh, S., Müller, D., Baechtold, M., Hauswirth, F., Probst, P., & Müller, M. K. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.10.017 · Cited by 1

Endoscopic Assessment Prior to Bariatric Surgery in Saudi Arabia

Aljaroudi, M. E., Makki, M., Almulaify, M. S., Alshabib, A., Alfaddagh, H., Alzahrani, H. A., Alghamdi, S., Alsualiman, W., Alsalman, J., & Alhaddad, M. J. (2023) · Cureus · doi:10.7759/cureus.36157 · Cited by 1

Which patient should have preference for liver transplantation: ALD?

Mazhar, A., Alnimer, L., & Piper, M. S. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000009 · Cited by 1

El Hígado graso (parte 2): enfoque clínico y tratamiento

Ortíz, J. E. P., Luque, C. B. S., & Quiróz, R. J. O. (2023) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.979 · Cited by 1

Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study

Roberts, R., Williams, D. M., Min, T., Barry, J. D., & Stephens, J. W. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01311-4 · Cited by 1

Research Progress on Multidisciplinary Intervention for Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Liver Cancer

Zhang, Y., & Xu, C. (2024) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2024.1211015 · Cited by 1

Ruptured hepatocellular carcinoma developed in a normal liver in a young patient with a body mass index of 33 kg/m2

Kirihata, N., Nakano, Y., Moriyoshi, K., & Miyamoto, S. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-262841 · Cited by 1

Impact of Metabolic Surgery on Cardiovascular Disease Outcomes

Piché, M., Poirier, P., & Wong, J. A. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.05.013 · Cited by 2

Role of Tissue Biopsy in Drug Development for Nonalcoholic Fatty Liver Disease and Other Metabolic Disorders

Krentz, A. J., & Bédossa, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_10 · Cited by 1

Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis

Le, L. B., Kullar, R., Saleh, H., & Saab, S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06382-4 · Cited by 1

Liver disease

McClain, C. J., Smart, L., Safadi, S., & Kirpich, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818460-8.00026-5 · Cited by 1

Rewiring of the Liver Transcriptome across Multiple Time-Scales Is Associated with the Weight Loss-Independent Resolution of NAFLD Following RYGB

Lei, P., Chukwudi, C. C., Pannu, P. R., He, S., & Saeidi, N. (2022) · Metabolites · doi:10.3390/metabo12040318 · Cited by 1

Hígado graso: Epidemiología, diagnóstico y tratamiento

Tagle, M. (2022) · Diagnóstico · doi:10.33734/diagnostico.v61i3.379

Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis

Zhou, H., Luo, P., Li, P., wang, G., Yi, X., Fu, Z., Sun, X., Cui, B., Zhu, L., & Zhu, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06011-1 · Cited by 79

Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis

Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511

Bariatric surgery improves nonalcoholic fatty liver disease: A contemporary systematic review and meta-analysis

Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259

Long-term Effects of Bariatric Surgery in Patients with Non-alcoholic Fatty Liver Disease: A Literature Review and Meta-Analysis

Wells, M. M., Schneier, A., Ganjoo, N., Schiano, T. D., & Pinotti, R. (2016) · The American Journal of Gastroenterology · doi:10.14309/00000434-201610001-00850

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology

Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A. W., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 261